Literature DB >> 19950315

Ambulatory visit utilization in a national, population-based sample of adults with osteoarthritis.

Miriam G Cisternas1, Edward Yelin, Jeffrey N Katz, Daniel H Solomon, Elizabeth A Wright, Elena Losina.   

Abstract

OBJECTIVE: To estimate the proportion of adults with osteoarthritis (OA) seeing various medical providers and ascertain factors affecting the likelihood of a patient seeing an OA specialist.
METHODS: We used data from the Medical Expenditures Panel Survey, a stratified random sample of the noninstitutionalized civilian population. We classified adults as having symptomatic OA if their medical conditions included at least 1 occurrence of the International Classification of Diseases, Ninth Revision Clinical Modification, codes 715, 716, or 719, and if they reported joint pain, swelling, or stiffness during the previous 12 months. For the purpose of our analysis, we defined rheumatologists, orthopedists, and physical therapists as OA specialists. We first estimated the proportion of OA individuals seen by OA specialists and other health care providers in a 1-year period. We then used logistic regression to estimate the impact of demographic and clinical factors on the likelihood of an individual seeing an OA specialist.
RESULTS: A total of 9,933 persons met the definition of OA, representing 22.5 million adults in the US. Of these persons, 92% see physicians during the year, 34% see at least 1 OA specialist, 25% see an orthopedist, 11% see a physical therapist, and 6% see a rheumatologist. Higher educational attainment, having more comorbidities, and residing in the northeastern US are significant positive predictors for a patient seeing an OA specialist. Significant negative predictors for seeing an OA specialist are being unmarried but previously married and having no health insurance.
CONCLUSION: Most adults with OA do not visit OA specialists. Those without insurance and with lower levels of education are less likely to see these specialists.

Entities:  

Mesh:

Year:  2009        PMID: 19950315      PMCID: PMC2836231          DOI: 10.1002/art.24897

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  29 in total

1.  Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs.

Authors:  S F Lanes; L L Lanza; P W Radensky; R A Yood; R F Meenan; A M Walker; N A Dreyer
Journal:  Arthritis Rheum       Date:  1997-08

2.  Joint and soft tissue injections: a survey of general practitioners.

Authors:  W G Liddell; C R Carmichael; N J McHugh
Journal:  Rheumatology (Oxford)       Date:  2005-05-11       Impact factor: 7.580

3.  Comparison of three comorbidity measures for predicting health service use in patients with osteoarthritis.

Authors:  Kelli L Dominick; Tara K Dudley; Cynthia J Coffman; Hayden B Bosworth
Journal:  Arthritis Rheum       Date:  2005-10-15

4.  Access to healthcare services among persons with osteoarthritis and rheumatoid arthritis.

Authors:  Kristofer J Hagglund; Mary J Clark; Shelley A Hilton; James E Hewett
Journal:  Am J Phys Med Rehabil       Date:  2005-09       Impact factor: 2.159

Review 5.  Costs, outcomes, and patient satisfaction by provider type for patients with rheumatic and musculoskeletal conditions: a critical review of the literature and proposed methodologic standards.

Authors:  D H Solomon; D W Bates; R S Panush; J N Katz
Journal:  Ann Intern Med       Date:  1997-07-01       Impact factor: 25.391

6.  Reduced utilization and cost of primary care clinic visits resulting from self-care education for patients with osteoarthritis of the knee.

Authors:  S A Mazzuca; K D Brandt; B P Katz; M P Hanna; C A Melfi
Journal:  Arthritis Rheum       Date:  1999-06

7.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.

Authors:  Reva C Lawrence; David T Felson; Charles G Helmick; Lesley M Arnold; Hyon Choi; Richard A Deyo; Sherine Gabriel; Rosemarie Hirsch; Marc C Hochberg; Gene G Hunder; Joanne M Jordan; Jeffrey N Katz; Hilal Maradit Kremers; Frederick Wolfe
Journal:  Arthritis Rheum       Date:  2008-01

8.  Knee osteoarthritis clinical practice guidelines -- how are we doing?

Authors:  Melanie N DeHaan; Jaime Guzman; Mark Theodore Bayley; Mary J Bell
Journal:  J Rheumatol       Date:  2007-08-15       Impact factor: 4.666

9.  Costs attributable to osteoarthritis.

Authors:  C H MacLean; K Knight; H Paulus; R H Brook; P G Shekelle
Journal:  J Rheumatol       Date:  1998-11       Impact factor: 4.666

10.  Access to medical care among persons with musculoskeletal conditions. A study using a random sample of households in San Mateo County, California.

Authors:  E Yelin; G Bernhard; D Pflugrad
Journal:  Arthritis Rheum       Date:  1995-08
View more
  11 in total

1.  Strategies for managing osteoarthritis.

Authors:  Norman Tiong Meng Ng; Kristiann C Heesch; Wendy J Brown
Journal:  Int J Behav Med       Date:  2012-09

2.  Physical activity levels and functional performance in the osteoarthritis initiative: a graded relationship.

Authors:  Dorothy D Dunlop; Jing Song; Pamela A Semanik; Leena Sharma; Rowland W Chang
Journal:  Arthritis Rheum       Date:  2011-01

3.  Physical therapy vs internet-based exercise training for patients with knee osteoarthritis: results of a randomized controlled trial.

Authors:  K D Allen; L Arbeeva; L F Callahan; Y M Golightly; A P Goode; B C Heiderscheit; K M Huffman; H H Severson; T A Schwartz
Journal:  Osteoarthritis Cartilage       Date:  2018-01-05       Impact factor: 6.576

4.  All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study.

Authors:  Eveline Nüesch; Paul Dieppe; Stephan Reichenbach; Susan Williams; Samuel Iff; Peter Jüni
Journal:  BMJ       Date:  2011-03-08

5.  STepped exercise program for patients with knee OsteoArthritis (STEP-KOA): protocol for a randomized controlled trial.

Authors:  Kelli D Allen; Dennis Bongiorni; Kevin Caves; Cynthia J Coffman; Theresa A Floegel; Heather M Greysen; Katherine S Hall; Bryan Heiderscheit; Helen M Hoenig; Kim M Huffman; Miriam C Morey; Shalini Ramasunder; Herbert Severson; Battista Smith; Courtney Van Houtven; Sandra Woolson
Journal:  BMC Musculoskelet Disord       Date:  2019-05-28       Impact factor: 2.362

6.  Small Extracellular Vesicles from adipose derived stromal cells significantly attenuate in vitro the NF-κB dependent inflammatory/catabolic environment of osteoarthritis.

Authors:  Carola Cavallo; Giulia Merli; Rosa Maria Borzì; Nicoletta Zini; Stefania D'Adamo; Michele Guescini; Brunella Grigolo; Alessandro Di Martino; Spartaco Santi; Giuseppe Filardo
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

7.  Physical Activity Types and Programs Recommended by Primary Care Providers Treating Adults With Arthritis, DocStyles 2018.

Authors:  Dana Guglielmo; Kristina A Theis; Louise B Murphy; Michael A Boring; Charles G Helmick; John D Omura; Erica L Odom; Lindsey M Duca; Janet B Croft
Journal:  Prev Chronic Dis       Date:  2021-10-14       Impact factor: 2.830

8.  Trends and Racial/Ethnic Differences in Health Care Spending Stratified by Gender among Adults with Arthritis in the United States 2011-2019.

Authors:  Antoinette L Spector; Emily Matsen; Leonard E Egede
Journal:  Int J Environ Res Public Health       Date:  2022-07-25       Impact factor: 4.614

9.  Clinic variation in recruitment metrics, patient characteristics and treatment use in a randomized clinical trial of osteoarthritis management.

Authors:  Kelli D Allen; Hayden B Bosworth; Ranee Chatterjee; Cynthia J Coffman; Leonor Corsino; Amy S Jeffreys; Eugene Z Oddone; Catherine Stanwyck; William S Yancy; Rowena J Dolor
Journal:  BMC Musculoskelet Disord       Date:  2014-12-06       Impact factor: 2.362

10.  Examining racial and ethnic trends and differences in annual healthcare expenditures among a nationally representative sample of adults with arthritis from 2008 to 2016.

Authors:  Antoinette L Spector; Sneha Nagavally; Aprill Z Dawson; Rebekah J Walker; Leonard E Egede
Journal:  BMC Health Serv Res       Date:  2020-06-12       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.